Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

“Our long-term analysis of tirzepatide establishes that clinically relevant weight loss can be sustained for ... in November 2023 by the US Food and Drug Administration (FDA) (Zepbound) and ...

For adults struggling with weight, a weekly injection of tirzepatide offers ... reveal that the drug leads to significant and lasting weight loss over three years. This could change how healthcare ...